Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actonel for Bone Loss Prevention in ALL and LL Patients
NCT00452439Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2004
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteoporosis, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2004; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00452439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452439.